How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis?
Glaucoma is a neurodegenerative disorder with established relationships with ocular structures such as the retinal nerve fibre layer (RNFL) and the ganglion cell layer (GCL). Ocular imaging techniques such as optical coherence tomography (OCT) allow for quantitative measurement of these structures. OCT has been used in the monitoring of glaucoma, as well as investigating other neurodegenerative conditions such as Alzheimer's disease (AD) and multiple sclerosis (MS). In this review, we highlight the association between these disorders and ocular structures (RNFL and GCL), examining their usefulness as biomarkers of neurodegeneration. The average RNFL thickness loss in patients with AD is 11 μm, and 7 μm in MS patients. Most of the studies investigating these changes are cross-sectional. Further longitudinal studies are required to assess sensitivity and specificity of these potential ocular biomarkers to neurodegenerative disease progression.
Department of Ophthalmology, King's College London, London, UK.
E
E
Jones-Odeh
Department of Ophthalmology, King's College London, London, UK.|Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.
C J
http://orcid.org/0000-0002-3227-2620
CJ
Hammond
D000544:Alzheimer Disease / Q000175:diagnosis / Q000503:physiopathology*; D015415:Biomarkers; D005901:Glaucoma / Q000175:diagnosis / Q000503:physiopathology*; D006801:Humans; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000503:physiopathology*; D009412:Nerve Fibers / Q000473:pathology*; D019636:Neurodegenerative Diseases / Q000175:diagnosis / Q000503:physiopathology*; D012165:Retinal Ganglion Cells / Q000473:pathology*
D015415:Biomarkers